Pharmafile Logo

TVF Communications

Novartis building

Novartis’ Zykadia claims US approval for first-line lung cancer

The Swiss pharma giant’s drug also receives CHMP positive opinion

- PMLiVE

Novo seeks to strengthen Tresiba label in US

Studies find insulin degludec advantage over insulin glargine

Rare diseases: meeting the challenge

Problems with regulating orphan drugs

- PMLiVE

FDA panel backs Puma’s breast cancer drug, with reservations

Side effects concerns could see medicines limited

- PMLiVE

Pfizer gets FDA panel recommendation for biosimilar EPO

Product could be the first direct competitor to Epogen and Procrit in the US

- PMLiVE

The false economy of following the leader

How can companies in the sector shake things up?

PEGASUS UNVEILS NEW BRAND IDENTITY AS IT CELEBRATES A YEAR AS PART OF ASHFIELD

Pegasus, an Ashfield company, part of UDG Healthcare plc, has unveiled a new brand identity signaling its successful integration with the global business, a year on from acquisition. Conceived by...

Inizio

- PMLiVE

Recordati acquires AstraZeneca blood pressure brands

Italian pharma firm obtains Seloken and Logimax

- PMLiVE

MSD probed by UK for blocking Remicade biosimilars

Pharma giant’s discount scheme for infliximab labelled ‘anti-competitive’

- PMLiVE

Biogen spin-out makes first acquisition

Bioverativ attains rare disease group True North

german flag

Germany’s pharma market set for stable growth

Annual growth of 4.9% expected over next four years

How personalising multichannel improves customer experience

You’ve started your multichannel journey, and your customer-facing staff are connecting healthcare professionals to new channels. Great! Providing content in other channels extends customer relationships. Now, with HCP access at...

Anthill Agency

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links